Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€13.80

€13.80

4.580%
0.6
4.580%
€20.00

€20.00

 
27.03.24 / Tradegate WKN: A1W6ND / Symbol: MGNX / Name: MacroGenics / Stock / Biotechnology & Medical Research / Small Cap /
Latest predictions
€20.00
25.03.24
3.76%
€21.20
29.02.24
-16.87%
buy
€20.00
04.02.24
-4.17%
buy
17.01.24
39.39%
buy
€11.86
20.12.23
45.26%
buy
€15.52
27.11.23
97.14%
buy
Best running prediction
-
02.09.23
205.80%
buy
Your prediction

MacroGenics Inc. Stock

MacroGenics Inc. dominated the market today, gaining €0.60 (4.580%).
With 9 Buy predictions and only 1 Sell predictions the community sentiment for the stock is positive.
With a target price of 20 € there is a positive potential of 44.93% for MacroGenics Inc. compared to the current price of 13.8 €.
Our community identified positive and negative aspects for MacroGenics Inc. stock for the coming years. 5 users see the criterium "Worthwhile Investment for the next years" as a plus for the MacroGenics Inc. stock. On the other hand our users think that "Valuation (undervalued/overvalued)" could be a problem in the future.

Pros and Cons of MacroGenics Inc. in the next few years

Pros
?
G***** c******* t* c**********
?
C******** o* t** e**********
?
B****
Cons
?
W********* I********* f** t** n*** y****
?
M***** P*******
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'

Performance of MacroGenics Inc. vs. its peers

Security Change(%) 1w 1m 1y YTD 3y 5y
MacroGenics Inc. 4.580% -2.817% -13.208% 120.800% 53.333% -51.064% -
Salarius Pharmaceuticals Inc. 2.420% -18.824% -22.617% -76.389% -25.405% -98.665% -99.992%
Ardelyx Inc. -1.160% -6.371% -22.654% 73.980% 16.955% 25.791% -
Evolus Inc -0.770% 2.362% -2.985% 66.667% 39.037% 31.287% -

Comments

Prediction Buy
Perf. (%) -16.87%
Target price 21.199
Change
Ends at 28.02.25

MacroGenics, Inc. (NASDAQ: MGNX) had its price target raised by analysts at Barclays PLC from $12.00 to $23.00. They now have an "overweight" rating on the stock.
Ratings data for MGNX provided by MarketBeat
Show more

Prediction Buy
Perf. (%) 45.26%
Target price 11.857
Change
Ends at 20.12.24

MacroGenics, Inc. (NASDAQ: MGNX) was upgraded by analysts at Citigroup Inc. from a "neutral" rating to a "buy" rating. They now have a $13.00 price target on the stock, up previously from $7.00.
Ratings data for MGNX provided by MarketBeat
Show more

Prediction Buy
Perf. (%) 97.14%
Target price 15.516
Change
Ends at 27.11.24

MacroGenics, Inc. (NASDAQ: MGNX) had its "buy" rating re-affirmed by analysts at Stifel Nicolaus. They now have a $17.00 price target on the stock.
Ratings data for MGNX provided by MarketBeat
Show more

News

MacroGenics (MGNX) Q4 2023 Earnings Call Transcript: https://g.foolcdn.com/editorial/images/1/featured-transcript-logo-template-2023-01-12.jpg
MacroGenics (MGNX) Q4 2023 Earnings Call Transcript

Image source: The Motley Fool.

MacroGenics (NASDAQ: MGNX)Q4 2023 Earnings CallMar 07, 2024, 4:30 p.m. ET

Operator

Continue reading

Source Fool.com

MacroGenics (MGNX) Q3 2023 Earnings Call Transcript: https://g.foolcdn.com/editorial/images/1/featured-transcript-logo-template-2023-01-12.jpg
MacroGenics (MGNX) Q3 2023 Earnings Call Transcript

Image source: The Motley Fool.

MacroGenics (NASDAQ: MGNX)Q3 2023 Earnings CallNov 06, 2023, 4:30 p.m. ET

Operator

Continue reading

Source Fool.com